Veracyte, Inc. stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Veracyte, Inc. stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Veracyte, Inc. do? Business model and key facts
Get the full picture of Veracyte, Inc.: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Employees (FY): 755
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Stocks related to Veracyte, Inc.
Selected based on industry alignment and relative market positioning.
Events and news impacting Veracyte, Inc. stock
Earnings, coporate decisions and industry developments that can affect the share price.
Veracyte, Inc. fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
